Both in Pharmaceuticals
Ardelyx vs Arbutus Biopharma
Over the past year ARDX returned −36.3% and ABUS returned −4.0%; their daily moves had a correlation of 0.24.
ARDX −36.3% ABUS −4.0%Growth of $1, one year, split-adjusted
| Metric | ARDX | ABUS |
|---|---|---|
| Price | $3.27 | $4.29 |
| Market cap | $844.3M | $849.9M |
| Today | +2.51% | +2.39% |
| 1 month | −3.5% | −15.0% |
| 6 months | −47.9% | −8.3% |
| Year to date | −43.9% | −10.8% |
| 1 year | −34.7% | +1.2% |
| Revenue growth (YoY) | +23.8% | −90.6% |
| Gross margin | 95.2% | 100.0% |
| Net margin | −13.8% | −512.0% |
| P/E (TTM) | — | 5.6× |
| Price / sales | 1.9× | 4.7× |
| Net cash | $30.0M | $89.5M |
| Dividend yield | — | — |
| Volatility (60d) | 48.8% | 37.2% |
| Short % of float | 11.4% | 21.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).